Clinical Trial Update: Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy [Phase 2]

View source ↗

Summary

The Phase 2 trial evaluating subcutaneous immunoglobulin for Multifocal Motor Neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multifocal Motor Neuropathy

Drugs mentioned

• Subcutaneous immunoglobulin (immunoglobulin)

Snippet

Sponsor: University of Aarhus | Conditions: Multifocal Motor Neuropathy | Phase 2 | Status: COMPLETED